Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 2/20 | 0.64 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.64 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7385540 | 1.00 | HTR3A (0.64) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL1821834 | 0.95 | HTR3A (0.70) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL62124 | 0.95 | HTR3A (0.70) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL31406725 | 0.95 | HTR3A (0.70) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL62123 | 0.95 | HTR3A (0.70) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL18311459 | 0.95 | HTR3A (0.70) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL7342367 | 0.94 | HTR3A (0.69) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL4828089 | 0.94 | HTR3A (0.69) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL4828092 | 0.94 | HTR3A (0.69) | HTR3AHTR4TMEM97SIGMAR1 | |
| Itasetron SCHEMBL8720455 | 0.93 | HTR3A (0.67) | HTR3AHTR4TMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0309423-B1 | New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists | BOEHRINGER INGELHEIM ITALIA (IT) | 1994-06-15 | — | — | EP | claimed |
| EP-0309423-A2 | New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists | BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) | 1989-03-29 | — | — | EP | claimed |
| US-5552408-A | Benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists | BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) | 1996-09-03 | — | — | US | disclosed |
| US-5358954-A | Antiserotonine agent, antiemetic, gastrointestinal disorders | BOEHRINGER INGELHEIM ITALIA (IT) | 1994-10-25 | — | — | US | disclosed |
| EP-0309423-B1 | New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists | BOEHRINGER INGELHEIM ITALIA (IT) | 1994-06-15 | — | — | EP | disclosed |
| US-5223511-A | Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists | BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) | 1993-06-29 | — | — | US | disclosed |
| EP-0309423-A2 | New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists | BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) | 1989-03-29 | — | — | EP | disclosed |